In the research, scientists aimed to compare the short-term consequences of transcatheter aortic valve implantation (TAVI) and surgical replacement of the aortic valve (SAVR). Patients aged 10 to 21 years old who had native SAVR or TAVI procedures performed between January 2010 and April 2020 were included in this retrospective, single-center study. When comparing SAVR and TAVI in terms of their baseline characteristics and a composite outcome (stroke within 6 months, readmission within 30 days, death), researchers employed either the chi-square test or the Wilcoxon rank sum test, depending on which one was most applicable. About 46 of the 77 patients undergoing native aortic valve implantation throughout the study period (60 SAVR, 17 TAVI) were between the ages of 10 and 21 (30 SAVR, 16 TAVI). For the SAVR group, the median follow-up was 3.8 years (interquartile range: 1.5 to 4.9), and for the TAVI group, it was 1.5 years (interquartile range: 1.1 to 1.2). There was no discernible difference in the overall result across the groups. Patients in the SAVR group were more likely to have undergone concurrent surgical intervention, and their hospital and intensive care unit stays were also longer on average. In summary, the research outcomes showed that SAVR and TAVI had similar short-term effects in adolescents and young people between the ages of 10 and 21. Longer-term research was required to understand the applicability of TAVI and the viability of a transcatheter approach as an alternative to SAVR in the treatment of juvenile patients.
- Business of Medicine
- Doctor’s Voice